
Please try another search
Benzinga - Analysts at Morgan Stanley downgraded Charles Schwab Corp (NYSE: SCHW) on Tuesday, citing concerns over cash sorting and regulatory changes.
Schwab CEO Walt Bettinger recently said that the company's banking unit had enough liquidity to cover if 100% of its bank deposits ran off without having to sell a single security — Morgan Stanley says otherwise.
Schwab’s recent performance has not been up to Morgan Stanley's expectations, with customers moving cash out of sweep accounts into money market funds at a rate twice that which the bank had been modeling.
The SCHW Analyst: Michael Cyprys downgraded Charles Schwab from Overwight to Equal Weight, and lowered its price target from $99 to $68.
Check out more Schwab ratings here.
Cyprys told investors that Schwab’s earnings are under more pressure than initially anticipated, and the company is facing $22 billion in unrealized losses due to rising rates.
Despite Bettinger’s comments last week, Morgan Stanley believes the bank may have to sell securities at a loss to fund future withdrawals.
Further, Morgan Stanley cut EPS estimates by 30% for 2023 and 2024, reflecting the latest trends in customer cash sorting and uncertainty around the rates outlook.
Cyprys expects Schwab to successfully navigate through its near-term challenges given its access to funding and balance sheet liquidity, but a meaningful deceleration in cash sorting, followed by a reset of earnings expectations, are necessary preconditions for the market to buy into a recovery story.
Lack of visibility into the abatement of cash sorting and the amount of wholesale funding required in the interim creates significant uncertainty around Schwab’s earnings trajectory, Cyprus said, making the investment risk/reward less compelling.
SCHW Price Action: Shares of Charles Schwab are trading 5.25% lower to $52.32, according to data from Benzinga Pro.
Next: Biden Eyes New Regulations As Congress Dives Into Silicon Valley, Signature Bank Failures
Latest Ratings for SCHW
Feb 2022 | Morgan Stanley | Maintains | Overweight | |
Jan 2022 | Deutsche Bank | Maintains | Buy | |
Jan 2022 | Argus Research | Maintains | Buy |
View the Latest Analyst Ratings
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.